Safety and Efficacy of Sodium-glucose Cotransporter 2 Inhibitors in Kidney Transplant Recipients With Pretransplant Type 2 Diabetes Mellitus: A Retrospective, Single-center, Inverse Probability of Treatment Weighting Analysis of 85 Transplant Patients

Whether sodium-glucose cotransporter 2 (SGLT2) inhibitors can be used effectively and safely in kidney transplant (KT) recipients with pretransplant type 2 diabetes as the primary cause of end-stage renal disease (ESRD) remains unclear. In this study, we retrospectively analyzed the efficacy and saf...

Descripción completa

Detalles Bibliográficos
Autores principales: Hisadome, Yu, Mei, Takanori, Noguchi, Hiroshi, Ohkuma, Toshiaki, Sato, Yu, Kaku, Keizo, Okabe, Yasuhiro, Nakamura, Masafumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Kidney Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8500668/
https://www.ncbi.nlm.nih.gov/pubmed/34646935
http://dx.doi.org/10.1097/TXD.0000000000001228

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8500668/
https://www.ncbi.nlm.nih.gov/pubmed/34646935
http://dx.doi.org/10.1097/TXD.0000000000001228

Ejemplares similares